These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 68401)

  • 1. Hormones and adjuvant chemotherapy in breast cancer.
    Anderson JM; Algie T; Grant JK; Gettinby G
    Lancet; 1977 Jun; 1(8025):1307. PubMed ID: 68401
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormones and breast cancer.
    Key TJ; Allen NE
    IARC Sci Publ; 2002; 156():273-6. PubMed ID: 12484186
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
    Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W
    PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients.
    Baumgart J; Nilsson K; Stavreus Evers A; Kunovac Kallak T; Kushnir MM; Bergquist J; Sundström Poromaa I
    Climacteric; 2014 Feb; 17(1):48-54. PubMed ID: 23647561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role?
    Alder J; Zanetti R; Wight E; Urech C; Fink N; Bitzer J
    J Sex Med; 2008 Aug; 5(8):1898-906. PubMed ID: 18554258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of treatment with tamoxifen on serum levels of various steroid and protein hormones in women with breast cancer].
    Grodecka-Gazdecka S; Kociałkowski K; Chwalisz K; Baron J
    Endokrynol Pol; 1985; 36(6):341-8. PubMed ID: 3833535
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormones in the aetiology and clinical course of breast cancer.
    Wang DY; Swain MC; Hayward JL; Bulbrook RD
    Recent Results Cancer Res; 1972; 39():177-83. PubMed ID: 4269002
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
    Coombes RC; Powles TJ; Rees LH; Ratcliffe WA; Nash AG; Henk M; Ford HT; Gazet JC; Neville AM
    Br J Cancer; 1982 Jul; 46(1):30-4. PubMed ID: 7104195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy.
    Ramírez-Expósito MJ; Sánchez-López E; Cueto-Ureña C; Dueñas B; Carrera-González P; Navarro-Cecilia J; Mayas MD; Arias de Saavedra JM; Sánchez-Agesta R; Martínez-Martos JM
    Exp Gerontol; 2014 Oct; 58():34-42. PubMed ID: 25019472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
    McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
    Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
    [No Abstract]   [Full Text] [Related]  

  • 11. Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder.
    Ochsenkühn R; Hermelink K; Clayton AH; von Schönfeldt V; Gallwas J; Ditsch N; Rogenhofer N; Kahlert S
    J Sex Med; 2011 May; 8(5):1486-94. PubMed ID: 21366876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
    Geisler J; Haynes B; Anker G; Helle H; Ekse D; Dowsett M; Lønning PE
    J Steroid Biochem Mol Biol; 2005 Sep; 96(5):415-22. PubMed ID: 16168635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sequential changes in hormone levels in postmenopausal breast cancer patients under long-term treatment with an aromatase inhibitor. Kanagawa AI Study Group].
    Fukuda M; Watanabe H; Suda T; Shimizu S
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2201-8. PubMed ID: 10635305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrinology of Zoladex in postmenopausal women.
    Dowsett M; Cantwell BM; Harris AL
    Horm Res; 1989; 32 Suppl 1():209-12. PubMed ID: 2533152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the plasma 17-beta-estradiol level using the radioisotope method of competitive bond in patients with cancer of the breast].
    Vitola GJ; Grabovska IK; Pismennaja AI
    Radiobiol Radiother (Berl); 1977; 18(5):613-8. PubMed ID: 609724
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone concentrations in postmenopausal patients with breast cancer.
    Jones MK; Ramsay ID; Booth M; Collins WP
    Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
    Clin Ter; 1991 Feb; 136(3):195-9. PubMed ID: 1827382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the impact of chemotherapy on fertility in women with breast cancer.
    Oktay K; Oktem O; Reh A; Vahdat L
    J Clin Oncol; 2006 Aug; 24(24):4044-6. PubMed ID: 16921067
    [No Abstract]   [Full Text] [Related]  

  • 20. The fate of 17 beta-estradiol in the plasma of premenopausal and postmenopausal patients with cancer.
    Vaughn CB; Kolakowski D; Zylka U; Brooks SC
    J Clin Endocrinol Metab; 1976 Aug; 43(2):387-93. PubMed ID: 950369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.